Literature DB >> 15841415

Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: a variant of corticobasal degeneration?

Chun-Feng Tan1, Yue-Shan Piao, Akiyoshi Kakita, Mitsunori Yamada, Hiroki Takano, Masaharu Tanaka, Atsushi Mano, Kunihiko Makino, Masatoyo Nishizawa, Koichi Wakabayashi, Hitoshi Takahashi.   

Abstract

We report two patients who exhibited frontotemporal dementia (FTD) with unusual neuropathological features. The ages of the patients at death were 65 and 67 years, the disease durations were 6 and 5 years, and the clinical diagnoses were Pick's disease and corticobasal degeneration (CBD), respectively. At autopsy, both cases exhibited neuropathological findings compatible with those of CBD, including atrophy of the frontal and parietal lobes, neuronal loss and gliosis in the cortical and subcortical regions, and presence of cortical ballooned neurons and astrocytic plaques (APs). In both cases, immunoblotting of insoluble tau exhibited the pattern of selective accumulation of four-repeat tau, a finding that is also compatible with CBD. However, severe degeneration was evident in the frontal and parietal white matter in both cases. Moreover, a striking finding was the widespread presence in the affected cortex of tufted astrocytes (TAs), which are characteristic of progressive supranuclear palsy (PSP). Neither co-occurrence of APs and TAs nor severe degeneration of the cerebral white matter is a feature of either CBD or PSP. No mutations were found in the tau gene in either case. In conclusion, the possibility that these two cases represent a new neuropathological phenotype of non-familial FTD rather than simply a variant of CBD cannot be completely excluded.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15841415     DOI: 10.1007/s00401-004-0933-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

Review 1.  Astrocyte and Alzheimer's disease.

Authors:  Zhiyou Cai; Cheng-Qun Wan; Zhou Liu
Journal:  J Neurol       Date:  2017-08-18       Impact factor: 4.849

2.  Globular glial tauopathy caused by MAPT P301T mutation: clinical and neuropathological findings.

Authors:  M E Erro; M V Zelaya; M Mendioroz; R Larumbe; S Ortega-Cubero; J L Lanciego; A Lladó; T Cabada; T Tuñón; F García-Bragado; M R Luquin; P Pastor; I Ferrer
Journal:  J Neurol       Date:  2019-06-12       Impact factor: 4.849

3.  Progressive supranuclear palsy and primary lateral sclerosis secondary to globular glial tauopathy: a case report and a practical theoretical framework for the clinical prediction of this rare pathological entity.

Authors:  Andy J Liu; Jessica E Chang; Georges Naasan; Adam L Boxer; Bruce L Miller; Salvatore Spina
Journal:  Neurocase       Date:  2020-02-23       Impact factor: 0.881

4.  Cortical Alzheimer type pathology does not influence tau pathology in progressive supranuclear palsy.

Authors:  Kenichi Oshima; Dennis W Dickson
Journal:  Int J Clin Exp Pathol       Date:  2008-12-20

5.  White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration.

Authors:  Gabor G Kovacs; Katalin Majtenyi; Salvatore Spina; Jill R Murrell; Ellen Gelpi; Romana Hoftberger; Graham Fraser; R Anthony Crowther; Michel Goedert; Herbert Budka; Bernardino Ghetti
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

6.  Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U.

Authors:  Kuen-Jer Tsai; Chun-Hung Yang; Yen-Hsin Fang; Kuan-Hung Cho; Wei-Lin Chien; Wei-Ting Wang; Tzu-Wei Wu; Ching-Po Lin; Wen-Mei Fu; Che-Kun James Shen
Journal:  J Exp Med       Date:  2010-07-26       Impact factor: 14.307

7.  Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure.

Authors:  Xuebing Ding; Mingming Ma; Junfang Teng; Robert K F Teng; Shuang Zhou; Jingzheng Yin; Ekokobe Fonkem; Jason H Huang; Erxi Wu; Xuejing Wang
Journal:  Oncotarget       Date:  2015-09-15

8.  Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.

Authors:  Shelley L Forrest; Jillian J Kril; Claire H Stevens; John B Kwok; Marianne Hallupp; Woojin S Kim; Yue Huang; Ciara V McGinley; Hellen Werka; Matthew C Kiernan; Jürgen Götz; Maria Grazia Spillantini; John R Hodges; Lars M Ittner; Glenda M Halliday
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.